Our Executive Leadership and Board of Directors
CEO and Managing Director
Stephen Blignaut
Stephen Blignaut is a visionary leader with a strong background in entrepreneurship and business management. Born in South Africa, Stephen made his mark in the investment education sector before relocating to Australia in 1997. He studied Business Administration at Griffith University and has successfully navigated diverse industries, including investment education, publishing, and medical aesthetics. Stephen’s experience in managing medical research on Fibroblast Growth Factors positions him at the forefront of innovation in the biotechnology field, driving ReGen Factor’s strategic vision and operational excellence.
Chief Scientific Officer
Dr. Keith Wai-Yeung Kwong
Dr. Keith Wai-Yeung Kwong is a pioneering scientist with a global reputation in biotechnology. His extensive expertise in recombinant proteins, vaccines, and regenerative medicine is reflected in his numerous patents and over 13 peer-reviewed publications. Dr. Kwong’s innovative work in bio-identical growth factors and stem cell technology propels ReGen Factor’s research and development, ensuring we remain at the cutting edge of scientific discovery. His leadership in advancing vaccine delivery systems underscores our commitment to developing transformative medical solutions.
Chief Financial Officer
Suraj Sanghani
Suraj Sanghani brings a wealth of experience in corporate governance and financial strategy to ReGen Factor. As a Chartered Accountant and Chartered Secretary, his expertise in financial management in both public and private companies is a cornerstone of our company’s sustainable growth. Suraj’s strategic insight and leadership ensure the robustness of our financial operations, securing our position as a leader in the global market. His commitment to excellence in governance and financial oversight is pivotal to our ongoing success.
Regulatory Affairs Advisor
Dr. Mukesh Kumar, Ph.D., RAC
Dr. Mukesh Kumar is an esteemed authority in regulatory affairs and clinical development. As the CEO of FDAMap, he provides unparalleled guidance in navigating the complexities of regulatory pathways and clinical trials. With leadership in over 150 clinical trials worldwide, Dr. Kumar’s expertise guarantees that ReGen Factor’s products meet the highest standards of regulatory compliance and quality assurance. His global perspective and deep understanding of regulatory environments ensure that our products are safe, effective, and market-ready.
Capital Raise Advisor
James Moses
James Moses, founder and managing director of Mandate Corporate, is a seasoned expert in investor relations and corporate communications. With a track record of guiding over 70 companies in transactions exceeding $1 billion, James is instrumental in securing financial resources and raising market awareness for ReGen Factor. His deep connections in investment markets and media, coupled with his experience in IPOs, mergers, and acquisitions, provide a solid foundation for our strategic capital raise efforts and ASX listing.